BALFX
Price
$37.50
Change
+$0.10 (+0.27%)
Updated
Aug 26 closing price
Net Assets
255.46B
PABCX
Price
$18.95
Change
+$0.06 (+0.32%)
Updated
Aug 26 closing price
Net Assets
1.03B
Interact to see
Advertisement

BALFX vs PABCX

Header iconBALFX vs PABCX Comparison
Open Charts BALFX vs PABCXBanner chart's image
American Funds American Balanced F1
Price$37.50
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets255.46B
PGIM Balanced C
Price$18.95
Change+$0.06 (+0.32%)
VolumeN/A
Net Assets1.03B
BALFX vs PABCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALFX vs. PABCX commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and PABCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 255B vs. PABCX (1.03B). BALFX pays higher dividends than PABCX: BALFX (1.79) vs PABCX (1.32). BALFX was incepted earlier than PABCX: BALFX (24 years) vs PABCX (29 years). PABCX (1.87) is less costly to investors than BALFX (0.61). PABCX is a more actively managed with annual turnover of: 107.00 vs. BALFX (44.00). BALFX has a lower initial minimum investment than PABCX: BALFX (250) vs PABCX (1000). BALFX annual gain was more profitable for investors over the last year : 7.21 vs. PABCX (3.57). BALFX return over 5 years is better than : 36.93 vs. PABCX (19.87).
BALFXPABCXBALFX / PABCX
Total Expense Ratio0.611.8134%
Annual Report Gross Expense Ratio0.611.8733%
Fund Existence24 years29 years-
Gain YTD9.9818.812113%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets255B1.03B24,685%
Annual Yield % from dividends1.791.32135%
Returns for 1 year7.213.57202%
Returns for 3 years34.1527.91122%
Returns for 5 years36.9319.87186%
Returns for 10 years71.9735.43203%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EOLS7.650.22
+2.96%
Evolus
TSLX24.150.09
+0.37%
Sixth Street Specialty Lending
RKDA3.970.01
+0.25%
Arcadia Biosciences
ICLR171.760.01
+0.01%
ICON plc
ABOS1.46-0.05
-3.31%
Acumen Pharmaceuticals